Hepatitis C and risk of coronary atherosclerosis – A systematic review

Public Health

Volumn 138, Issue , 2016, Pages 12-25

  Olubamwo, O O ^a   Aregbesola, A O ^a   Miettola, J ^a   Kauhanen, J ^a   Tuomainen, T P ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Coronary artery disease; HCV; Inflammation; Meta analysis; Myocardial infarction

Indexed keywords

CARDIOVASCULAR DISEASE; HEALTH RISK; HEPATITIS; META-ANALYSIS;

CASE CONTROL STUDY; CHRONIC HEPATITIS C; COHORT ANALYSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; OBSERVATIONAL STUDY; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; CORONARY ARTERY DISEASE; HEPATITIS C, CHRONIC; META ANALYSIS; RISK;

HEPATITIS C VIRUS; SCOPUS;

CORONARY ARTERY DISEASE; HEPATITIS C, CHRONIC; HUMANS; RISK;

EID: 84969141887     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2016.04.005     Document Type: Review

References (35)

1. 1 Shepard, C.W., Finelli, L., Alter, M.J., Lancet Infect Dis 5 (2005), 558–567.
2. 2 Ndzengue, A., Kim, T.H., Shire, A.M., Roberts, L.R., Hepatitis C virus: epidemiology and clinical features of related cancer. In viruses and human cancer, 2014, Springer, 87–112.
3. 3 Zignego, A., Ferri, C., Pileri, S., Caini, P., Bianchi, F., Dig Liver Dis 39 (2007), 2–17.
4. 4 Ishizaka, N., Ishizaka, Y., Takahashi, E., Tooda, E., Hashimoto, H., Nagai, R., et al. Lancet 359 (2002), 133–135.
5. 5 Matsumori, A., Circ Res 96 (2005), 144–147.
6. 6 Vassalle, C., Masini, S., Bianchi, F., Zucchelli, G.C., Heart 90 (2004), 565–566.
7. 7 Satapathy, S.K., Kim, Y.J., Kataria, A., Shifteh, A., Bhansali, R., Cerulli, M.A., et al. J Clin Exp Hepatol 3 (2013), 186–191.
8. 8 Davies, M.J., Circulation 85 (1992), I19–I24.
9. 9 Singh, R.B., Mengi, S.A., Xu, Y., Arneja, A.S., Dhalla, N.S., Exp Clin Cardiol, 7, 2002, 40.
10. 10 Papazafiropoulou, A., Katsilambros, N., Tentolouris, N., Open Biomarkers J 1 (2008), 36–47.
11. 11 Kiechl, S., Egger, G., Mayr, M., Wiedermann, C.J., Bonora, E., Oberhollenzer, F., et al. Circulation 103 (2001), 1064–1070.
12. 12 Zampino, R., Marrone, A., Restivo, L., Guerrera, B., Sellitto, A., Rinaldi, L., et al. World J Hepatol, 5, 2013, 528.
13. 13 Ishizaka, Y., Ishizaka, N., Takahashi, E., Unuma, T., Tooda, E., Hashimoto, H., et al. Circ J 67 (2003), 26–30.
14. 14 Alyan, O., Kacmaz, F., Ozdemir, O., Deveci, B., Astan, R., Celebi, A.S., et al. Circ J 72 (2008), 1960–1965.
15. 15 Caliskan, Y., Oflaz, H., Püsüroglu, H., Boz, H., Yazici, H., Tamer, S., et al. Clin Nephrol 71 (2009), 147–157.
16. 16 Forde, K., Haynes, K., Troxel, A., Trooskin, S., Osterman, M., Kimmel, S., et al. J Viral Hepat 19 (2012), 271–277.
17. 17 Karbasi-Afshar, R., Adibi, P., Khedmat, H., Jalali, A.R., Int J Travel Med Glob Health 1 (2013), 55–64.
18. 18 Wong, R.J., Kanwal, F., Younossi, Z.M., Ahmed, A., Dig Dis Sci, 2014, 1–8.
19. 19 Roed, T., Lebech, A., Kjaer, A., Weis, N., Clin Physiol Funct Imaging 32 (2012), 421–430.
20. 20 Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, et al. URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp; 2011.
21. 21 Butt, A.A., Xiaoqiang, W., Budoff, M., Leaf, D., Kuller, L.H., Justice, A.C., Clin Infect Dis 49 (2009), 225–232, 10.1086/599371.
22. 22 Forde, K.A., Haynes, K., Troxel, A.B., Trooskin, S., Osterman, M.T., Kimmel, S.E., et al. J Viral Hepat 19 (2012), 271–277, 10.1111/j.1365-2893.2011.01545.x.
23. 23 Tsui, J.I., Whooley, M.A., Monto, A., Seal, K., Tien, P.C., Shlipak, M., J Card Fail 15 (2009), 451–456, 10.1016/j.cardfail.2008.12.003.
24. 24 Pothineni, Naga Venkata Krishna Chand, Delongchamp, R., Vallurupalli, S., Ding, Z., Dai, Y., Hagedorn, C.H., et al. Am J Cardiol 114 (2014), 1841–1845.
25. 25 Arcari, C.M., Nelson, K.E., Netski, D.M., Nieto, F.J., Gaydos, C.A., Clin Infect Dis 43 (2006), e53–e56, 10.1086/507031.
26. 26 Butt, A.A., Khan, U.A., McGinnis, K.A., Skanderson, M., Kent Kwoh, C., J Viral Hepat 14 (2007), 890–896, 10.1111/j.1365-2893.2007.00885x.
27. 27 Momiyama, Y., Ohmori, R., Kato, R., Taniguchi, H., Nakamura, H., Ohsuzu, F., Atherosclerosis 181 (2005), 211–213, 10.1016/j.atherosclerosis.2005.02.027.
28. 28 Ramdeen, N., Aronow, W.S., Chugh, S., Asija, A., Hypertension, 75, 2008, 75.
29. 29 Younossi, Z., Stepanova, M., Nader, F., Younossi, Z., Elsheikh, E., Aliment Pharmacol Ther 37 (2013), 647–652.
30. 30 Adinolfi, L.E., Restivo, L., Guerrera, B., Sellitto, A., Ciervo, A., Iuliano, N., et al. Atherosclerosis 231 (2013), 22–26.
31. 31 Akhtar, B., Hanif, A., Qureshi, N., Hussain, S., Siddique, K., Khan, B.Z., et al. Ann King Edw Med Univ, 2011, 16.
32. 32 Adinolfi, L.E., Zampino, R., Restivo, L., Lonardo, A., Guerrera, B., Marrone, A., et al. World J Gastroenterol, 20, 2014, 3410.
33. 33 Riordan, S., Skinner, N., Kurtovic, J., Locarnini, S., McIver, C., Williams, R., et al. Inflamm Res 55 (2006), 279–285.
34. 34 Bruunsgaard, H., Skinhøj, P., Pedersen, A.N., Schroll, M., Pedersen, B., Clin Exp Immunol 121 (2000), 255–260.
35. 35 Roed, T., Kristoffersen, U.S., Knudsen, A., Wiinberg, N., Lebech, A., Almdal, T., et al. Vasc Health Risk Manag, 10, 2014, 55.